3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
20
Neoplasm Metastasis
8
Leukemia, Myeloid, Acute
7
Skin Neoplasms
6
Ovarian Neoplasms
6
Lymphoma, Non-Hodgkin
6
Colorectal Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Leukemia, Lymphocytic, Chronic, B-Cell
5
Uveal Melanoma
4
Stomach Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Neoplasms
4
Triple Negative Breast Neoplasms
3
Recurrence
3
Rectal Neoplasms
3
Pancreatic Neoplasms
3
Mesothelioma, Malignant
3
Lymphoma, Follicular
3
Lymphoma
3
Lung Neoplasms
3
Leukemia
3
Esophageal Neoplasms
3
Carcinoma, Renal Cell
3
Uterine Cervical Neoplasms
2
Sarcoma
2
Pleural Effusion, Malignant
2
Neuroblastoma
2
Myelodysplastic Syndromes
2
Multiple Myeloma
2
Interventions
Cytarabine
4
venetoclax
2
Mitoxantrone
2
Daunorubicin
2
Cladribine
2
thymoglobulin
1
quizartinib
1
pegylated granulocyte colony-stimulating factor
1
fludarabine phosphate
1
fludarabine
1
blinatumomab
1
Transplantation
1
Thiotepa
1
Tacrolimus
1
Sorafenib
1
Sirolimus
1
Rituximab
1
Razoxane
1
Mesna
1
Melphalan
1
Leyk
1
Idarubicin
1
Granulocyte Colony-Stimulating Factor
1
Gemtuzumab
1
Filgrastim
1
Etoposide
1
Dexrazoxane
1
Cyclophosphamide
1
Bortezomib
1
Azacitidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma, Myeloid
×
Interleukin-2
×
1 year
×
Clear all
No trials found.